ALGT, ORN, CRWE, AMAP - CRWESelect.com Stock News! Allegiant Travel Company, Orion Marine Group, Crown Equity Holdings, AutoNavi
(IBI, CRWE, ABTL, ORN) CRWEWallStreetNewsAlert.com Stock Market Report
(TCHC, CRWE, ORN, QLTI) PennyOmega.com Stock Market Activity
(MOSY, ORN, FSII) PennyOmega.com Watch List for Wed Feb. 08, 2012
(ATHX, ORN, CACI) PennyOmega.com Watch List for Thursday Feb. 02, 2012
ORN, Orion Marine Group Inc.
** ORN reported a contract award of approximately $12 million.
ORN was recently awarded a berth construction contract for the Canaveral Port Authority in Florida. Work consists of the construction of two ship docks and dredging at the site to deepen the berths to the appropriate depth.
(FTR, GBLHF, ORN, MJGCF, CBK) Noticeable Stocks by CRWESelect.com
Frontier Communications Corporation (NYSE:FTR) paid its Third-Quarter dividend to shareholders on Friday, September 30, 2011 and announced that its Board of Directors has reaffirmed its current intention to maintain the annual dividend of $0.75 per share of the Company's common stock.
ORN, GHM, WRC, - CRWESelect.com Stocks To Watch! Orion Marine Group, Graham, The Warnaco Group ( Video Included Inside )
To View Video Click or Visit URL Link Here: http://crweselect.com/26107/stock-alerts/orn-ghm-wrc-crweselectcom-stock...
Orion Marine Group, Inc. (NYSE:ORN)
(ORN, GHM, WRC) PennyOmega.com Watch List for Friday Sept. 09, 2011
ORN, ORFG.PK, PWRM.OB, - CRWESelect's Stocks To Watch Are Orion Marine Group, Orofino Gold Corp. and Power3 Medical!
Orion Marine Group, Inc (NYSE:ORN) provides a broad range of marine construction and specialty services on, over and under the water along the Gulf Coast, the Atlantic Seaboard, the West Coast, Canada, and the Caribbean Basin and acts as a single source turn-key solution for its customers' marine contracting needs.
ORN previously reported a contract award of approximately $11 million.
(NOR, PWRM, ORN, BOB.V, STM) Market Watch From PennyOmega.com
Power3 Medical Products, Inc. (OTC.BB:PWRM) announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.